Rates of arrhythmic events and death remained common in patients indicated for implantable cardioverter defibrillator or ...

The Food and Drug Administration (FDA) has cleared the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD).

Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.

coarse ventricular fibrillation). Once therapy is administered, the patient’s physician is automatically notified via the Jewel mobile app. The therapy report contains a digital representation ...

The man from Sarawak had collapsed without warning shortly after his flight landed. Read more at straitstimes.com. Read more at straitstimes.com.

The incident was shared on Facebook by cardiologist Dr Tang Sie Heng, who posted the account on behalf of the man's family.

A new study has found 56 lifestyle factors that could help prevent most cases of sudden cardiac arrest, according to the ...

A devastated mum has told of the moment her teenage daughter was diagnosed with a rare disease - after previous seizures had ...

VT can degenerate to ventricular fibrillation as ischemia and hypotension develop, particularly in patients with impaired ventricular function. Although scars from a healed myocardial infarction ...

The OLYSENSE Platform with the CADDIE device is part of a total portfolio of ADR solutions and technologies that will be ...

The ejection fraction (EF) on echo is 25%. In general, an ICD is not implanted when VT or ventricular fibrillation (VF) occurs so early in the course of acute MI. While long-term follow-up data ...

Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.